CARLOS
MACAYA MIGUEL
Profesor emérito
![Foto de CARLOS](/img/nophoto.png)
![Foto de KU Leuven](/img/noimage_org.png)
KU Leuven
Lovaina, BélgicaPublicaciones en colaboración con investigadores/as de KU Leuven (5)
2016
-
Relationship between arterial access and outcomes in ST-elevation myocardial infarction with a pharmacoinvasive versus primary percutaneous coronary intervention strategy: Insights from the STrategic reperfusion early after myocardial infarction (STREAM) study
Journal of the American Heart Association, Vol. 5, Núm. 6
2009
-
Enoxaparin Versus Unfractionated Heparin in Elective Percutaneous Coronary Intervention. 1-Year Results From the STEEPLE (SafeTy and Efficacy of Enoxaparin in Percutaneous coronary intervention patients, an internationaL randomized Evaluation) Trial
JACC: Cardiovascular Interventions, Vol. 2, Núm. 11, pp. 1083-1091
2008
-
Impact of anticoagulation levels on outcomes in patients undergoing elective percutaneous coronary intervention: Insights from the STEEPLE trial
European Heart Journal, Vol. 29, Núm. 4, pp. 462-471
2006
-
Enoxaparin versus unfractionated heparin in elective percutaneous coronary intervention
New England Journal of Medicine, Vol. 355, Núm. 10, pp. 1006-1017
2004
-
Direct stenting versus direct stenting followed by centered beta-radiation with intravascular ultrasound-guided dosimetry and long-term anti-platelet treatment. Results of a randomized trial: Beta-Radiation Investigation with Direct stenting and Galileo in Europe (BRIDGE)
Journal of the American College of Cardiology, Vol. 44, Núm. 3, pp. 528-537